Resetting the immune balance in patients with autoimmunity, chronic inflammatory diseases, and cancer by targeting dendritic cells with particulated antigen and adjuvant
Dendritic cell-modulating therapeutics for disease-specific immunity or tolerance to restore the immune balance
We assembled a consortium of academic partners and companies that were previously not interlinked. We envision fruitful long-term collaborations in the fields of immunomonitoring, cellular therapy, and nano delivery systems.
In many diseases, the immune system plays an important role. Worldwide, millions of lives can be saved by immune-modulating curative cancer treatments (over 8 million worldwide annually). Furthermore, hundreds of millions of chronic inflammatory diseases (5 to 7% of the Western society) and patients suffering from allergies (10-30% of the world population) would benefit from a curative immune-modulating treatment approach rather than life-long daily treatments.
In DC4Balance, disease-overarching insight in DC modulating therapeutics was gained. A harmonised immunological toolbox was developed. Unique longitudinal patient samples from previously performed immunotherapy trials by the consortium members in different diseases were analysed. The aligned outcome in all assays confirms the robustness and power of the immunomonitoring toolbox for studying the effect of DC modulating therapies. The toolbox will be available for upcoming trials in the consortium for which sufficient patient material will be available and will allow for further alignment with therapy efficacy.
In addition, we developed nano systems that can modulate and activate dendritic cells. Particulated adjuvants/antigens were used to modulate DC function. Mechanisms are deciphered for reprogramming immune responses in cancer and chronic inflammatory diseases. Novel DC-modulating therapeutics are developed ready to be produced according to good manufacturing guidelines (GMP) for clinical application of a broad range of immune disorders.
Taken together, this project has laid the foundations for curative treatments for immune-mediated diseases. The potential societal and economic impact of this project is therefore huge.
Andere projecten
In elk PPS-project werken kennisinstellingen, bedrijven en zorgpartijen samen aan een concrete gezondheidsvraag. Bekijk het volledige projectoverzicht.
Bekijk de programma’s
Binnen onze programma’s werken bedrijven, kennisinstellingen en regionale partners samen aan innovaties die bijdragen aan betere gezondheid en zorg.
Bekijk de partnerschappen
Strategische publiek-private partnerschappen (PPP's) zijn meerjarige samenwerkingen tussen bedrijven, kennisinstellingen en andere partijen.
Hoe kunnen we je helpen?
Heb je een vraag of wil je meer weten over Health Holland? We brengen je graag in contact met de juiste mensen, kennis en mogelijkheden om gezondheidsinnovatie te versnellen.
We hebben uw bericht ontvangen
We nemen binnen 3 tot 4 werkdagen contact met je op. Is je vraag dringend? Neem dan gerust direct contact met ons op. Hieronder zie je de contactoptie die het beste past bij je onderwerp.
Opnieuw beginnen
Er ging iets mis bij het versturen van het formulier. Probeer het opnieuw.